BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15724934)

  • 1. [Efficacy and tolerance of stepwise therapy with movalis in rheumatic diseases].
    Tsetkova ES
    Ter Arkh; 2004; 76(12):78-80. PubMed ID: 15724934
    [No Abstract]   [Full Text] [Related]  

  • 2. [Meloxicam (Movalis)].
    Kaliterna DM
    Reumatizam; 2007; 54(2):81-2. PubMed ID: 18351150
    [No Abstract]   [Full Text] [Related]  

  • 3. [New aspects of anti-inflammatory therapy of rheumatic diseases: preclinical validation and clinical trial of meloxicam].
    Nasonov EL; Tsvetkova ES; Balabanova RM; Denisov LN; Alekseeva LI; Nasonova VA
    Klin Med (Mosk); 1996; 74(4):4-8. PubMed ID: 8999152
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharma-Clinics. The drug of the month. Meloxicam (Mobic)].
    Scheen AJ
    Rev Med Liege; 1997 Apr; 52(4):309-11. PubMed ID: 9273628
    [No Abstract]   [Full Text] [Related]  

  • 5. [New information on clinical efficacy and tolerance of meloxicam (movalis)].
    Nasonova VA
    Ter Arkh; 1999; 71(11):45-8. PubMed ID: 10626335
    [No Abstract]   [Full Text] [Related]  

  • 6. [Meloxicam: intramuscular administration in rheumatology].
    Tsvetkova ES
    Ter Arkh; 2003; 75(8):96-7. PubMed ID: 14520864
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety of meloxicam: a global analysis of clinical trials [British Journal of Rheumatology, 1996;35(suppl. 1):68-77].
    Fenn GC; Morant SV
    Br J Rheumatol; 1997 Jul; 36(7):817-9. PubMed ID: 9255122
    [No Abstract]   [Full Text] [Related]  

  • 8. [Meloxicam--the balance of efficacy and safety].
    Morović-Vergles J
    Reumatizam; 2008; 55(2):85-6. PubMed ID: 19024285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective cyclooxygenase inhibition: promise for future NSAID therapy?
    Fries JF
    Scand J Rheumatol Suppl; 1996; 102():1. PubMed ID: 8628977
    [No Abstract]   [Full Text] [Related]  

  • 10. [The evaluation of the effectiveness and tolerance of movalis in patients with osteoarthrosis].
    Iakushin SS; Filonenko SP; Kosov IN; Sorokina OS
    Klin Med (Mosk); 1999; 77(6):47-9. PubMed ID: 10459221
    [No Abstract]   [Full Text] [Related]  

  • 11. [Efficacy and intolerance of meloxicam in injection and tablet form].
    Tiurin VP; Rakov AL
    Voen Med Zh; 2003 Nov; 324(11):54-8. PubMed ID: 14725079
    [No Abstract]   [Full Text] [Related]  

  • 12. [Multicenter study of Felden 20 suppositories in 3887 patients].
    von Criegern T
    Med Welt; 1983 Nov; 34(45):1290-3. PubMed ID: 6358773
    [No Abstract]   [Full Text] [Related]  

  • 13. [Movalis treatment of low back pain (LBP)].
    Shostak NA; Aksenova AV; Shemetov DA; Arinina EE
    Ter Arkh; 1999; 71(11):50-2. PubMed ID: 10626337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of movalis in marked neurological manifestations of lumbar osteochondrosis].
    Al'-Zamil' MKh
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(9):53-4. PubMed ID: 16250580
    [No Abstract]   [Full Text] [Related]  

  • 15. [Movalis in osteoarthritis (results of Russian research)].
    Tsvetkova ES
    Ter Arkh; 1999; 71(11):48-50. PubMed ID: 10626336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Safety and efficacy of movalis injected into trigger points in lumbago-ischialgia syndrome].
    Shirokov VA; Potaturko AV; Zakharov IaIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(9):41-4. PubMed ID: 18833170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Movalis in treatment of painful shoulder syndrome in poststroke patients].
    Batysheva TT; Kostenko EV; Ryl'skiĭ AV; Boĭko AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(12):60-1. PubMed ID: 15849867
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experience with movalis administration against osteoarthritis in Moscow clinics].
    Kogan KM; Zolotareva GD; Shmidt EI
    Ter Arkh; 1999; 71(11):52-4. PubMed ID: 10626338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of subsyde-CR versus meloxicam in rheumatic disorders.
    Patel BR
    J Indian Med Assoc; 2000 May; 98(5):250-2. PubMed ID: 11002624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of meloxicam in an observational, controlled cohort study in patients with rheumatic disease.
    Degner F; Sigmund R; Zeidler H
    Clin Ther; 2000 Apr; 22(4):400-10. PubMed ID: 10823362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.